BERIL-1: Biomarker results from targeted sequencing of circulating tumor DNA (ctDNA) and archival tissue in a randomized phase II study of buparlisib (BKM120) or placebo plus paclitaxel in patients ...

Researchers have developed and validated a machine learning--based method to predict which patients with early-stage melanoma are most likely to experience a cancer recurrence. Most deaths from ...

Researchers at Penn’s Abramson Cancer Center and Perelman School of Medicine recently discovered how to find and treat dormant cancer cells to help identify — and prevent recurrence in breast cancer ...